JPRN-jRCTc030220555招募中1 期
Multicenter clinical study of i.v. injected 2DG-Killer T cell therapy in patients with malignant tumors.
Goto Shigenori0 个研究点目标入组 6,000 人开始时间: 2022年1月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Diagnostic imaging or Pathological diagnosis of malignant tumor.
- •(2)Informed consent has been obtained.
排除标准
- •(1)HIV Ab positive.
- •(2)T cell- or NK cell-originated leukemia and/or lymphoma.(LAK therapy)
- •(3)Patients who have previously treated allogenic transplantation.
- •(4)Responsible doctors judged the patient inappropriate for the clinical study.
研究者
相似试验
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030190254Goto Shigenori6,000
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030220632Goto Shigenori6,000
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030190251Goto Shigenori6,000
招募中
不适用
Prospective study on the efficacy of intravenous glucocorticoid therapy in Japanese patients with Graves' ophthalmopathy.JPRN-UMIN000021482Kurume University Medical Center300
已完成
2 期
Comparison of the effect of ketorolac and morphine on pain control in patients with renal colicRenal colic.Unspecified renal colicIRCT20200825048515N40Shahre-kord University of Medical Sciences272